- Pieris Pharmaceuticals (NASDAQ:PIRS): Q2 GAAP EPS of -$0.25 beats by $0.02.
- Revenue of $3.29M (-70.8% Y/Y) beats by $1.21M.
- Cash and cash equivalents totaled $119.1M for the quarter ended June 30, 2021, compared to a cash and cash equivalents balance of $70.4M for the year ended December 31, 2020.
- Press Release
Pieris Pharmaceuticals EPS beats by $0.02, beats on revenue
Recommended For You
More Trending News
About PIRS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PIRS | - | - |
Pieris Pharmaceuticals, Inc. |